{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:55:25Z","timestamp":1772150125228,"version":"3.50.1"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,10,24]]},"DOI":"10.18632\/oncotarget.20982","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T20:02:46Z","timestamp":1505764966000},"page":"88730-88750","source":"Crossref","is-referenced-by-count":32,"title":["Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis"],"prefix":"10.18632","volume":"8","author":[{"given":"Liuqing","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongrui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfeng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchen","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andong","family":"Qiu","sequence":"additional","affiliation":[{"name":"School of Life Sciences and Technology, Advanced Institute of Translational Medicine, Tongji University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shougang","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"},{"name":"Department of Medicine, Rhode Island Hospital and Brown University School of Medicine, Providence, RI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/labinvest.2014.91","article-title":"MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis","volume":"94","author":"Lan","year":"2014","journal-title":"Lab Invest"},{"key":"2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3747\/pdi.2014.00195","article-title":"Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial","volume":"36","author":"Idzham","year":"2016","journal-title":"Perit Dial Int"},{"key":"3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/nep.12741","article-title":"Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment","volume":"22","author":"Li","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2013.02.027","article-title":"Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis","volume":"421","author":"Rios","year":"2013","journal-title":"Clin Chim Acta"},{"key":"5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","article-title":"Preventing peritoneal membrane fibrosis in peritoneal dialysis patients","volume":"90","author":"Selgas","year":"2016","journal-title":"Kidney Int"},{"key":"6","doi-asserted-by":"crossref","first-page":"3543678","DOI":"10.1155\/2016\/3543678","article-title":"Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis","volume":"2016","author":"Tripodi","year":"2016","journal-title":"Stem Cells Int"},{"key":"7","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.ajpath.2015.08.009","article-title":"Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis","volume":"185","author":"Asahina","year":"2015","journal-title":"Am J Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1681\/ASN.2013101079","article-title":"Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury","volume":"25","author":"Lin","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3747\/pdi.2014.00188","article-title":"Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?","volume":"35","author":"Chen","year":"2015","journal-title":"Perit Dial Int"},{"key":"10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0028-1082388","article-title":"TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation","volume":"26","author":"Chegini","year":"2008","journal-title":"Semin Reprod Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ajpath.2014.04.014","article-title":"Opposing roles for Smad2 and Smad3 in peritoneal fibrosisand","volume":"184","author":"Lan","year":"2014","journal-title":"Am J Pathol"},{"key":"12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10157-015-1128-9","article-title":"High glucose promotes TGF-\u03b21 production by inducing FOS expression in human peritoneal mesothelial cells","volume":"20","author":"Masaki","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"13","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2015030299","article-title":"Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis","volume":"27","author":"Zhuang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/jpet.114.215228","article-title":"Suramin inhibits the development and progression of peritoneal fibrosis","volume":"351","author":"Yan","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10157-011-0533-y","article-title":"Mechanisms and interventions in peritoneal fibrosis","volume":"16","author":"Tomino","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vph.2015.04.006","article-title":"Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes","volume":"72","author":"Jeong","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00795-016-0133-8","article-title":"Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-\u03baB activation","volume":"49","author":"Izumikawa","year":"2016","journal-title":"Med Mol Morphol"},{"key":"18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ki.2014.209","article-title":"Janus kinase signaling activation mediates peritoneal inflammation and injuryandin response to dialysate","volume":"86","author":"Adler","year":"2014","journal-title":"Kidney Int"},{"key":"19","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"L\u00f3pez-Cabrera","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1681\/ASN.2015101169","article-title":"IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane","volume":"28","author":"J\u00f6rres","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1523-1755.2002.00143.x","article-title":"Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells","volume":"61","author":"Sitter","year":"2002","journal-title":"Kidney Int"},{"key":"22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ki.2013.217","article-title":"The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation","volume":"84","author":"J\u00f6rres","year":"2013","journal-title":"Kidney Int"},{"key":"23","doi-asserted-by":"crossref","first-page":"e60776","DOI":"10.1371\/journal.pone.0060776","article-title":"Functional relevance of the switch of VEGF receptors\/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition","volume":"8","author":"L\u00f3pez-Cabrera","year":"2013","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/089686080902900604","article-title":"Factors contributing to peritoneal tissue remodeling in peritoneal dialysis","volume":"29","author":"van den Born","year":"2009","journal-title":"Perit Dial Int"},{"key":"25","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1016\/j.celrep.2017.03.012","article-title":"Identification of a Tissue-Restricted Isoform of SIRT1 Defines a Regulatory Domain that Encodes Specificity","volume":"18","author":"Kolthur-Seetharam","year":"2017","journal-title":"Cell Reports"},{"key":"26","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.27131","article-title":"Epigenetics in liver disease","volume":"60","author":"Mann","year":"2014","journal-title":"Hepatology"},{"key":"27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.110.168385","article-title":"Histone deacetylase: a potential therapeutic target for fibrotic disorders","volume":"335","author":"Zhuang","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3747\/pdi.2013.00089","article-title":"SAHA Suppresses Peritoneal Fibrosis in Mice","volume":"35","author":"Kohno","year":"2015","journal-title":"Perit Dial Int"},{"key":"29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1042\/CS20160084","article-title":"The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease","volume":"130","author":"Advani","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/epi.14.69","article-title":"Histone deacetylase 6 in health and disease","volume":"7","author":"Diederich","year":"2015","journal-title":"Epigenomics"},{"key":"31","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally","volume":"28","author":"Matthias","year":"2008","journal-title":"Mol Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1582-4934.2011.01493.x","article-title":"Rapamycin inhibits transforming growth factor \u03b2-induced peritoneal angiogenesis by blocking the secondary hypoxic response","volume":"16","author":"Margetts","year":"2012","journal-title":"J Cell Mol Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"F502","DOI":"10.1152\/ajprenal.00546.2016","article-title":"Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury","volume":"312","author":"Liu","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"34","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Kozikowski","year":"2010","journal-title":"J Am Chem Soc"},{"key":"35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1681\/ASN.2011050493","article-title":"Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis","volume":"23","author":"Zhuang","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"36","doi-asserted-by":"crossref","first-page":"473134","DOI":"10.1155\/2014\/473134","article-title":"Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis","volume":"2014","author":"L\u00f3pez-Cabrera","year":"2014","journal-title":"Adv Med"},{"key":"37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1440-1797.2007.00881.x","article-title":"Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction","volume":"12","author":"Kohno","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11255-016-1430-9","article-title":"The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells","volume":"49","author":"Park","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"39","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1681\/ASN.2015040457","article-title":"Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression","volume":"27","author":"Zhuang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3747\/pdi.2013.00317","article-title":"Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats","volume":"35","author":"Tomino","year":"2015","journal-title":"Perit Dial Int"},{"key":"41","first-page":"50","article-title":"Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through \u03b2-catenin signaling","volume":"32","author":"Margetts","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int"},{"key":"43","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1096\/fj.12-219378","article-title":"LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation","volume":"27","author":"Tager","year":"2013","journal-title":"FASEB J"},{"key":"44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.RES.0000118599.25944.D5","article-title":"Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability","volume":"94","author":"Dong","year":"2004","journal-title":"Circ Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ki.2009.436","article-title":"Smad3-dependent and -independent pathways are involved in peritoneal membrane injury","volume":"77","author":"Margetts","year":"2010","journal-title":"Kidney Int"},{"key":"46","doi-asserted-by":"crossref","first-page":"e49418","DOI":"10.1371\/journal.pone.0049418","article-title":"HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"47","first-page":"1","article-title":"Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-\u03baB signaling pathway","volume":"10","author":"Zhiying","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000326953","article-title":"Angiogenesis in peritoneal dialysis","volume":"34","author":"Beelen","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semnephrol.2011.01.006","article-title":"Determinants of peritoneal membrane function over time","volume":"31","author":"Lambie","year":"2011","journal-title":"Semin Nephrol"},{"key":"50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"51","doi-asserted-by":"crossref","first-page":"e44265","DOI":"10.1371\/journal.pone.0044265","article-title":"Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"52","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1038\/emboj.2011.298","article-title":"Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin","volume":"30","author":"Urbich","year":"2011","journal-title":"EMBO J"},{"key":"53","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood-2011-10-387365","article-title":"Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma","volume":"119","author":"Eda","year":"2012","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T20:04:50Z","timestamp":1750881890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":53,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017,10,24]]}},"alternative-id":["20982","29179471"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20982","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}